NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

DCVax, assuming the trial top line numbers confirm what is widely believed here, would clearly become, together with surgery and chemo, the SOC for GBM, or at least for the patients with best response, though I think it would be used for all patients unless indications are that it is counter productive or not helpful for certain sub-groups. But I definitely don’t see it as second line.